抗氧化剂与细胞凋亡：卡维地洛减轻阿霉素诱导的心肌病 - Suppr

Suppr

超能文献

Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol.

作者信息

Armstrong Stephen C

出版信息

J Mol Cell Cardiol. 2004 Oct;37(4):817-21. doi: 10.1016/j.yjmcc.2004.07.001.

DOI:10.1016/j.yjmcc.2004.07.001

PMID:15380672

Abstract

摘要

相似文献

Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol.抗氧化剂与细胞凋亡：卡维地洛减轻阿霉素诱导的心肌病

J Mol Cell Cardiol. 2004 Oct;37(4):817-21. doi: 10.1016/j.yjmcc.2004.07.001.

Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro.卡维地洛可预防阿霉素在体外诱导的心肌细胞自由基释放和凋亡。

J Mol Cell Cardiol. 2004 Oct;37(4):837-46. doi: 10.1016/j.yjmcc.2004.05.024.

Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.卡维地洛可预防阿霉素诱导的线粒体心肌病。

Toxicol Appl Pharmacol. 2002 Dec 15;185(3):218-27. doi: 10.1006/taap.2002.9532.

Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy.早期给予卡维地洛可预防阿霉素诱导的心肌病。

J Pharmacol Exp Ther. 2015 Dec;355(3):516-27. doi: 10.1124/jpet.115.225375. Epub 2015 Oct 28.

Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats.卡维地洛对阿霉素诱导的大鼠心肌病的保护作用。

Life Sci. 1999;65(12):1265-74. doi: 10.1016/s0024-3205(99)00362-8.

Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.卡维地洛介导的抗氧化保护作用对抗阿霉素诱导的心脏线粒体毒性。

Toxicol Appl Pharmacol. 2004 Oct 15;200(2):159-68. doi: 10.1016/j.taap.2004.04.005.

Carvedilol: just another Beta-blocker or a powerful cardioprotector?卡维地洛：只是另一种β受体阻滞剂还是一种强效心脏保护剂？

Cardiovasc Hematol Disord Drug Targets. 2006 Dec;6(4):257-66. doi: 10.2174/187152906779010746.

Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol.药物诱导的心脏线粒体毒性与保护：从多柔比星到卡维地洛。

Curr Pharm Des. 2011;17(20):2113-29. doi: 10.2174/138161211796904812.

Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.叶酸通过调节内皮型一氧化氮合酶减少阿霉素诱导的心肌病。

J Cell Mol Med. 2017 Dec;21(12):3277-3287. doi: 10.1111/jcmm.13231. Epub 2017 Jun 13.

Fighting doxorubicin-induced cardiotoxicity with adiponectin.用脂联素对抗阿霉素诱导的心脏毒性。

Cardiovasc Res. 2011 Feb 1;89(2):262-4. doi: 10.1093/cvr/cvq393. Epub 2010 Dec 14.

引用本文的文献

MD-1 Deficiency Accelerates Myocardial Inflammation and Apoptosis in Doxorubicin-Induced Cardiotoxicity by Activating the TLR4/MAPKs/Nuclear Factor kappa B (NF-κB) Signaling Pathway.MD-1 缺乏通过激活 TLR4/MAPKs/Nuclear Factor kappa B（NF-κB）信号通路加速多柔比星诱导的心脏毒性中的心肌炎症和细胞凋亡。

Med Sci Monit. 2019 Oct 22;25:7898-7907. doi: 10.12659/MSM.919861.

Myricitrin Protects against Doxorubicin-Induced Cardiotoxicity by Counteracting Oxidative Stress and Inhibiting Mitochondrial Apoptosis via ERK/P53 Pathway.杨梅素通过对抗氧化应激和经由ERK/P53途径抑制线粒体凋亡来预防阿霉素诱导的心脏毒性。

Evid Based Complement Alternat Med. 2016;2016:6093783. doi: 10.1155/2016/6093783. Epub 2016 Sep 14.

Apoptosis in Anthracycline Cardiomyopathy.蒽环类药物所致心肌病中的细胞凋亡

Curr Pediatr Rev. 2011 Nov;7(4):329-336. doi: 10.2174/157339611796892265.

Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart.阿霉素激活芳香烃受体可介导心脏的细胞保护作用。

Cardiovasc Res. 2011 May 1;90(2):305-14. doi: 10.1093/cvr/cvr007. Epub 2011 Jan 13.

The art of healing broken hearts in breast cancer patients: Trastuzumab and heart failure.乳腺癌患者心碎综合征的治疗：曲妥珠单抗与心力衰竭

Exp Clin Cardiol. 2009 Fall;14(3):e62-7.

Cardiomyocyte death in doxorubicin-induced cardiotoxicity.蒽环类抗生素诱导的心脏毒性中的心肌细胞死亡。

Arch Immunol Ther Exp (Warsz). 2009 Nov-Dec;57(6):435-45. doi: 10.1007/s00005-009-0051-8. Epub 2009 Oct 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验